Our data demonstrate that the ratio of proBDNF/BDNF and MMP-9 activity complement each other in the presence of OAB, and that this can be directly linked to microRNA activity and common metabolic comorbidities highly prevalent in the aging population (e.g., systemic arterial hypertension, dyslipidemia, and impaired glucose tolerance). Here, BDNF is linked to metabolic syndrome.